What are the economic benefits of prevention?
Chronic diseases are associated with significant costs to the health system, such as hospitalisations and charges to Medicare, as well as broader economic or societal costs. Prevention not only lowers healthcare costs, it reduces the costs to the economy associated with premature death and years spent in ill health. Prevention ensures fiscal sustainability for Australia.
Page contents
A range of economic benefits
The economic benefits of preventive health range from macroeconomic benefits, such as improvements in gross domestic product (GDP), to other societal benefits such as reduced environmental impacts and healthcare system cost savings.
Prevention benefits employers and businesses. If chronic disease is prevented, employees spend less time off work (absenteeism), and do not have reduced capacity at work due to ill health (presenteeism).
In 2017, the Productivity Commission conservatively estimated that Australia’s GDP could be increased by $4 billion per year if the health of people in fair or poor health was improved. 1
A more sustainable healthcare system and increased productivity
Our research indicates preventing chronic conditions leads to a more sustainable healthcare system and increased productivity through increased attendance at work and more productive years in the workforce. Increased productivity also produces improved GDP. 2
Reduced hospitalisations and absenteeism
Prevention leads to reduced hospitalisations and reduced absenteeism and presenteeism, which is associated with income lost due to disease and premature death.
What is the value of prevention to the economy?
Many preventive health interventions generate economic benefits. 3
Australians who are in good health are better able to lead fulfilling and productive lives, participate fully in their communities, education and work.
Every dollar spent on treating chronic disease that is preventable is money that could be spent elsewhere in the health sector; every year of productive life lost to premature death or disability could have been directed to a more productive and prosperous society.2
Examples of the economic value of prevention
Is prevention cost-effective?
Many preventive health interventions may be highly cost-effective for governments. Some promote health and reduce costs overall because of the reduced need to treat expensive diseases. Others allow Australians to live longer with better quality of life, and come at a reasonable cost to the health system. 3
Most preventive health strategies lead to cost savings that far outweigh the cost of their implementation. Research shows that cost savings have been achieved particularly from multiple strategies in tobacco control, but also from interventions targeting physical activity, diet and obesity.2
The types of interventions that are particularly cost-effective tend to have the largest population health impact. These include regulatory strategies, such as mandatory salt reduction and reformulation 7, restrictions on advertising unhealthy food to children, tobacco control restrictions, and fiscal interventions such as taxation of unhealthy or harmful products like tobacco 8, alcohol 9 and sugary drinks 10.
How can we make the economic argument for prevention?
It can be challenging to make the economic case for preventive health interventions as the benefits of prevention can take many years to become evident.
Modelling is a good way to understand the long-term economic benefits of prevention. For example, the Prevention Centre’s dynamic simulation modelling work provides a ‘what if’ tool through which to test various policy scenarios over time to see which are likely to be the most effective and cost-effective, both for individuals and the system as a whole.
Health economics can be used to inform decision making through the lens of efficiency. Health economics can answer questions related to how best to perform healthcare activities, whether a program should be funded, and what the right mix of activities should be to maximise health with the limited healthcare resources.
Increasingly, it is recognised that preventive health interventions are complex, with actions required across various sectors and impacts on other areas in society. Therefore, various methods may be required for the effectiveness and cost-effectiveness evaluation of these interventions. 11
Health economics is also concerned with equity. There are specific techniques that can be used to guide decision-makers on the equity impact of their decisions.
Note
As risk factors associated with chronic disease are impacted by all sectors of society, it is important to examine the economic benefits of interventions across various sectors. Despite a large body of literature, evidence gaps remain, particularly in terms of reporting on non-health co-benefits of prevention and collecting data for economic evaluations to demonstrate the economic benefits of prevention.
To demonstrate the full value of prevention, researchers and policy makers need to ensure they are measuring a range of health and non-health outcomes, including physical health, mental health, social, environmental and/or economic outcomes. Economic costs and benefits of preventive strategies also need to be routinely collected to enable more rigorous economic evaluations and costings of interventions. 2
More about prevention
-
What are the benefits of prevention for health and wellbeing?
Preventing chronic disease helps people to lead their best possible life. It avoids strain on the health budget and communities. -
What are the co-benefits of prevention?
Addressing the root causes of chronic disease can sometimes also benefit other sectors. A co-benefits approach can help governments prioritise action. -
What is the burden of chronic disease?
Burden of disease measures the impact of living with disease and injury and premature death. Chronic diseases are the leading causes of death in Australia. -
What is prevention?
Prevention – also called preventive health – is defined as any action taken to keep people healthy and well, and prevent or avoid risk of poor health, illness, injury and early death.
Find out more
The publications and other resources listed in the references below may be useful to those looking for more detailed and in-depth evidence around the benefits of chronic disease prevention.
- Productivity Commission. Shifting the Dial: 5 Year Productivity Review, Report No. 84. 2017. Canberra. https://www.pc.gov.au/inquiries/completed/productivity-review/report
- Howse, E, Crosland, P, Rychetnik, L, Wilson, A. The value of prevention: An Evidence Review. The Australian Prevention Partnership Centre, 2021. https://preventioncentre.org.au/resources/the-value-of-prevention/
- Jackson H, Shiell A. Preventive health: How much does Australia spend and is it enough? Canberra, Australia: Foundation for Alcohol Research and Education; 2017. https://fare.org.au/wp-content/uploads/Preventive-health-How-much-does-Australia-spend-and-is-it-enough_FINAL.pdf
- Zapata-Diomedi B, Brown V, Veerman JL. An evidence review and modelling exercise: The effects of urban form on health: Costs and benefits. The Australian Prevention Partnership Centre; 2015. https://preventioncentre.org.au/resources/the-effects-of-urban-form-on-health-costs-and-benefits/
- PwC. Weighing the cost of obesity: A case for action. A study on the additional costs of obesity and benefits of intervention in Australia. PricewaterhouseCoopers; 2015. https://www.pwc.com.au/pdf/weighing-the-cost-of-obesity-final.pdf
- Health Technology Analysts Pty Ltd. The Potential Impact of Salt Reduction in Australia. Sydney, Australia: The George Institute for Global Health; 2020. https://www.georgeinstitute.org/sites/default/files/documents/potential-impact-of-salt-reduction-in-australia.pdf
- Gebreslassie M, Sampaio F, Nystrand C, Ssegonja R, Feldman I. Economic evaluations of public health interventions for physical activity and healthy diet: A systematic review. Preventive Medicine. 2020;136. doi: 10.1016/j.ypmed.2020.106100
- Stockings E, Hall WD, Lynskey M, Morley KI, Reavley N, Strang J, et al. Prevention, early intervention, harm reduction, and treatment of substance use in young people. The Lancet Psychiatry. 2016;3(3):280-96. doi:10.1016/S2215-0366(16)00002-X; Chamberlain C, Perlen S, Brennan S, Rychetnik L, Thomas D, Maddox R, et al. Evidence for a comprehensive approach to Aboriginal tobacco control to maintain the decline in smoking: An overview of reviews among Indigenous peoples. Systematic Reviews. 2017;6(1). doi: 10.1186/s13643-017-0520-9
- Harris M, Fatema K, Spooner C, Harris-Roxas B, Mahimbo A, Barr M, et al. Review of effectiveness of certain healthy lifestyle interventions to reduce alcohol consumption, increase levels of physical activity and healthy eating and reduce overweight and obesity (2014-2019). An Evidence Check rapid review brokered by the Sax Institute for the Cancer Institute NSW. Sydney, Australia: Sax Institute; 2019. https://www.saxinstitute.org.au/publications/evidence-check-library/review-of-effectiveness-of-certain-healthy-lifestyle-interventions-2014-2019/
- Ananthapavan J, Sacks G, Brown V, Moodie M, Nguyen P, Veerman L, Mantilla Herrera AM, Lal A, Peeters A, Carter R. Priority-setting for obesity prevention-The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study. PLoS One. 2020 Jun 19;15(6):e0234804. doi: 10.1371/journal.pone.0234804. PMID: 32559212; PMCID: PMC7304600.
- Skivington K, Matthews L, Simpson SA, Craig P, Baird J, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. British Medical Journal. 2021 Sep 30;374. https://www.bmj.com/content/374/bmj.n2061
- Systematic review: Value of statistical life estimates for Australia
The value of a statistical life (VSL) estimates individuals’ willingness to trade wealth for mortality risk reduction. This study updated the VSL recommended for Australian policy appraisals. - The value of prevention
The review builds on previous work that has considered the health and other benefits of prevention and the cost-effectiveness of preventive health interventions particularly in terms of chronic disease prevention. - Ananthapavan J, Moodie M, Milat AJ, Carter R. Systematic Review to Update ‘Value of a Statistical Life’ Estimates for Australia. International Journal of Environmental Research and Public Health. 2021;18(11):6168. doi:10.3390/ijerph18116168
- Ananthapavan J, Sacks G, Brown V, Moodie M, Nguyen P, et al. Priority-setting for obesity prevention—The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study. PLOS ONE. 2020; 15(6): e0234804. doi:10.1371/journal.pone.0234804
- Ananthapavan J, Nguyen PK, Bowe S.J. et al. Cost-effectiveness of community-based childhood obesity prevention interventions in Australia. Int J Obes. 2019; 43:1102–1112. doi:10.1038/s41366-019-0341-0
- Ananthapavan J, Sacks G, Brown V, Moodie M, Nguyen P, Barendregt J, Veerman L, Mantilla Herrera A, Lal A, Peeters A, Carter, R. Assessing Cost-Effectiveness of Obesity Prevention Policies in Australia 2018 (ACE-Obesity Policy). Melbourne, Australia: Deakin University; 2018. http://www.aceobesitypolicy.com.au/
- Black N, Kung C, Peeters A. For richer, for poorer: the relationship between adolescent obesity and future household economic prosperity. Preventive Medicine. 2018; 111:142-150. doi: 10.1016/j.ypmed.2018.02.034
- Cadilhac D, Magnus A, Cumming T, Sheppard L, Pearce D, Carter R. The health and economic benefits of reducing disease risk factors – Research Report. VicHealth; 2009. https://www.vichealth.vic.gov.au/media-and-resources/publications/health-and-economic-benefits-of-reducing-disease-risk-factors
- Crosland P, Ananthapavan J, Davison J, Lambert M, Carter R. The health burden of preventable disease in Australia: a systematic review. Aust N Z J Public Health. 2019;43(2):163-70. doi:10.1111/1753-6405.12882
- Crosland P, Ananthapavan J, Davison J, Lambert M, Carter R. The economic cost of preventable disease in Australia: a systematic review of estimates and methods. Aust N Z J Public Health. 2019. doi:10.1111/1753-6405.12925
- Drummond M, Claxton K, Sculpher MJ, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Fourth edition. Oxford University Press; 2015. https://pure.york.ac.uk/portal/en/publications/methods-for-the-economic-evaluation-of-health-care-programmes(8f69bcee-cdac-44fa-871c-f821470df60a)/export.html
- Edwards RT, Lawrence CL. ‘What You See is All There is’: The Importance of Heuristics in Cost-Benefit Analysis (CBA) and Social Return on Investment (SROI) in the Evaluation of Public Health Interventions. Appl Health Econ Health Policy. 2021; 19, 653–664. doi:10.1007/s40258-021-00653-5
- Edwards RT, & McIntosh E (Eds). Applied Health Economics for Public Health Practice and Research. Oxford, UK: Oxford University Press; 2019. https://oxfordmedicine.com/view/10.1093/med/9780198737483.001.0001/med-9780198737483
- Greenhalgh E, Hurley S, Lal A. 17.4 Economic evaluations of tobacco control interventions. In: Greenhalgh E, Scollo M, Winstanley M, editors. Tobacco in Australia: Facts and issues. Melbourne, Australia: Cancer Council Victoria; 2020. https://www.tobaccoinaustralia.org.au/chapter-17-economics/17-4-economic-evaluations-of-tobacco-control-interventions
- Health Technology Analysts Pty Ltd. The Potential Impact of Salt Reduction in Australia. Sydney, Australia: The George Institute for Global Health; 2020. https://www.georgeinstitute.org/sites/default/files/documents/potential-impact-of-salt-reduction-in-australia.pdf
- NSW Ministry of Health. Reviewing economic evaluations: A checklist. Sydney, Australia: Centre for Epidemiology and Evidence, Population and Public Health Division, NSW Ministry of Health; 2021. Available from: https://www.health.nsw.gov.au/research/Publications/reviewing-economic-evaluations.pdf
- NSW Ministry of Health. Planning economic evaluations: A checklist. Sydney, Australia: Centre for Epidemiology and Evidence, Population and Public Health Division, NSW Ministry of Health; 2021. Available from: https://www.health.nsw.gov.au/research/Publications/planning-economic-evaluations.pdf
- NSW Ministry of Health. Commissioning Economic Evaluations: A Guide. Evidence and Evaluation Guidance Series. Sydney, Australia: Centre for Epidemiology and Evidence, Population and Public Health Division, NSW Ministry of Health; 2017. Available from: https://www.health.nsw.gov.au/research/Publications/commissioning-economic-evaluations.pdf
- NSW Treasury. Technical guide: Outcomes measurement for social impact investment proposals to the NSW Government. Sydney, Australia: Office of Social Impact Investment, NSW Treasury; 2018. Available from: http://www.osii.nsw.gov.au/assets/office-of-social-impact-investment/files/Technical-guide-for-outcomes-measurement.pdf
- PwC. Weighing the cost of obesity: A case for action. A study on the additional costs of obesity and benefits of intervention in Australia. PricewaterhouseCoopers; 2015. https://www.pwc.com.au/pdf/weighing-the-cost-of-obesity-final.pdf
- Smith J, Whetton S, d’Abbs P. The social and economic costs and harms of alcohol consumption in the NT. Darwin, Menzies School of Health Research; 2019. https://alcoholreform.nt.gov.au/__data/assets/pdf_file/0007/658249/social-costs-alcohol-consumption-nt.pdf
- Vos T, Carter R, Barendregt J, Mihalopoulos C, Veerman JL, Magnus A, Cobiac L, Bertram MY, Wallace AL, ACE–Prevention Team. Assessing Cost-Effectiveness in Prevention (ACE–Prevention): Final Report. University of Queensland, Brisbane and Deakin University, Melbourne; 2010. Available from: https://public-health.uq.edu.au/files/571/ACE-Prevention_final_report.pdf
- WHO. Tackling NCDs: ‘best buys’ and other recommended interventions for the prevention and control of noncommunicable diseases. Geneva, Switzerland: World Health Organization; 2017. https://apps.who.int/iris/handle/10665/259232